Discover 53 paid clinical trials in Bowling Green, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 53
Featured
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for
Diabetes Mellitus, Type 2, Hypertension,
Location: Bowling Green KY, Owensboro KY, Lexington KY,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07064473
Phase3, Recruiting
Active & Responsive
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for
Cardiovascular Disease
Location: Bowling Green KY, Nashville TN, Tullahoma TN,
Sponsor: Amgen
Sex: All
Age: 50 - 70+
Code: NCT07136012
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects
for
Elevated Blood Pressure, Hypertension
Location: Bowling Green KY, Cleveland TN, Chicago IL,
Sponsor: Zona Health, Inc
Sex: All
Age: 22+
Code: NCT06843577
Recruiting
Active & Responsive
Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care
for
Arthritis, Rheumatoid
Location: Bowling Green KY, Huntsville AL, Tupelo MS,
Sponsor: Crescendo Bioscience
Sex: All
Age: 18 - 70+
Code: NCT02832297
Recruiting
Active & Responsive
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
for
Atopic Dermatitis
Location: Bowling Green KY, Nashville TN, Mason OH,
Sponsor: Apogee Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07003425
Phase2, Recruiting
Active & Responsive
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
for
Psoriasis, Overweight or Obesity
Location: Bowling Green KY, Smyrna TN, Plainfield IN,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06857942
Recruiting
Active & Responsive
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
for
Plaque Psoriasis
Location: Bowling Green KY, Rolling Meadows IL, Detroit MI,